Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3beta signaling in hepatocytes
Ming-Ju Hsieh, Kuang-Ping Lan, Hao-Yu Liu, Xiao-Zong Zhang, Yaw-Feng Lin, Tzy-Yen Chen and Hui-Ling Chiou
BMC Gastroenterology 2012, 12:74 doi:10.1186/1471-230X-12-74
Published: 21 June 2012
Abstract (provisional)
Background
Hepatitis C virus (HCV) infection may cause liver diseases of various severities ranging from primary acute infection to life-threatening diseases, such as cirrhosis or hepatocellular carcinoma with poor prognosis. According to clinical findings, HCV infection may also lead to some extra-hepatic symptoms, including type 2 diabetes mellitus (DM). Since insulin resistance is the major etiology for type 2 DM and numerous evidences showed that HCV infection associated with insulin resistance, the involvement of E2 in the pathogenesis of type 2 DM and underlying mechanisms were investigated in this study.
Results
Results showed that E2 influenced on protein levels of insulin receptor substrate-1 (IRS-1) and impaired insulin-induced Ser308 phosphorylation of Akt/PKB and Ser9 phosphorylation of GSK3beta in Huh7 cells, leading to an inhibition of glucose uptake and glycogen synthesis, respectively, and eventually insulin resistance.
Conclusions
Therefore, HCV E2 protein indeed involved in the pathogenesis of type 2 DM by inducing insulin resistance.
Competing interests: The authors declare that they have no competing interests
Authors' Contributions:
Ming-Ju Hsieh has made substantive intellectual contributions to a published study and drafted the manuscript.
Kuang-Ping Lan, Hao-Yu Liu, Xiao-Zong Zhang and Yaw-Feng Lin have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data.
Shun-Fa Yang and Hui-Ling Chiou conceived of the study, and participated in its design and coordination and helped to draft the manuscript.
All authors read and approved the final manuscript.
No comments:
Post a Comment